| CEO: | Stephen O'Hara |
| Finance Director: | David Blain |
| Non-Executive Chairman: | Neil Davidson |
| Research and Development Director: | Sofia Kolyda |
| Non-Executive Dir: | Sean Christie |
| Address: | Innovation Centre, Innovation Way, York, United Kingdom, YO10 5DG |
| Phone: | + 44 (0) 203 178 5618 |
| Website: | http://www.optibiotix.com |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BP0RTP38 |
| Currency | UK Pounds |
| Share Price | 5.54p |
| Change Today | -0.060p |
| % Change | -1.07 % |
| 52 Week High | 8.35 |
| 52 Week Low | 4.80 |
| Volume | 28,264 |
| Shares Issued | 103.30m |
| Market Cap | £5.72m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:19 | 3,840 @ 5.50p |
| 15:49 | 4,852 @ 5.65p |
| 14:42 | 15,502 @ 5.51p |
| 10:29 | 829 @ 5.70p |
| 10:12 | 2,241 @ 5.51p |
| CEO | Stephen O'Hara |
| Finance Director | David Blain |
You are here: research